NASDAQ:CME - CME Group Stock Price, News, & Analysis

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group declared a quarterly dividend on Wednesday, August 8th. Shareholders of record on Monday, September 10th will be paid a dividend of $0.70 per share on Tuesday, September 25th. This represents a $2.80 annualized dividend and a yield of 1.65%. The ex-dividend date is Friday, September 7th. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) announced its quarterly earnings data on Thursday, July, 26th. The financial services provider reported $1.74 EPS for the quarter, topping the consensus estimate of $1.72 by $0.02. The financial services provider earned $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The business's quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.22 EPS. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Thursday, October, 25th 2018. View Earnings Estimates for CME Group.

13 Wall Street analysts have issued 12 month price targets for CME Group's shares. Their predictions range from $133.00 to $197.00. On average, they anticipate CME Group's stock price to reach $169.5385 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price. View Analyst Price Targets for CME Group.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CME Group.

Some companies that are related to CME Group include Intercontinental Exchange (ICE), T. Rowe Price Group (TROW), DEUTSCHE BOERSE/ADR (DBOEY), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD) and Primus Guaranty (PRSG).

Media coverage about CME stock has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CME Group earned a news and rumor sentiment score of 0.14 on Accern's scale. They also gave headlines about the financial services provider an impact score of 49.50 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for CME Group.

CME Group's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.49%), Edgewood Management LLC (2.31%), Janus Henderson Group PLC (1.81%), Bank of New York Mellon Corp (1.10%), Wells Fargo & Company MN (1.09%) and Waddell & Reed Financial Inc. (1.07%). Company insiders that own CME Group stock include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Phupinder Gill, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Millennium Management LLC, Waddell & Reed Financial Inc., PointState Capital LP, Wells Fargo & Company MN, Russell Investments Group Ltd. and Point72 Asset Management L.P.. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Renaissance Technologies LLC, Unigestion Holding SA, KAMES CAPITAL plc, Standard Life Aberdeen plc, Robeco Institutional Asset Management B.V., Edgewood Management LLC and Vontobel Asset Management Inc.. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $169.38.

CME Group has a market capitalization of $55.65 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]